Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PODD

Insulet Corporation

Sep 12 • 04:00PM ET

341.78

+3.84 1.14 %

Healthcare • Medical Devices • USA • NASD

Peers: DXCM JNJ ABT MDT EW SYK TNDM BSX BAX LIVN

| Held by: VTI VOO SPY IVV VB VO XLV RSP IWP VUG

Scroll to Statements

Index	S&P 500	P/E	104.01	EPS (ttm)	3.29	Insider Own	0.52%	Shs Outstand	70.39M	Perf Week	-1.91%
Market Cap	24.06B	Forward P/E	58.71	EPS next Y	5.82	Insider Trans	-6.76%	Shs Float	70.03M	Perf Month	10.72%
Enterprise Value	24.35B	PEG	3.34	EPS next Q	1.15	Inst Own	101.36%	Short Float	2.31%	Perf Quarter	12.57%
Income	236.10M	P/S	10.20	EPS this Y	43.44%	Inst Trans	-1.08%	Short Ratio	2.44	Perf Half Y	39.69%
Sales	2.36B	P/B	16.45	EPS next Y	25.27%	ROA	7.44%	Short Interest	1.62M	Perf YTD	30.92%
Book/sh	20.78	P/C	21.45	EPS next 5Y	31.10%	ROE	19.18%	52W High	353.50 -3.32%	Perf Year	50.90%
Cash/sh	15.93	P/FCF	60.86	EPS past 3/5Y	186.88% 98.82%	ROIC	9.83%	52W Low	225.28 51.71%	Perf 3Y	30.03%
Dividend Est.	-	EV/EBITDA	47.82	Sales past 3/5Y	23.54% 22.92%	Gross Margin	71.48%	Volatility	3.22% 2.19%	Perf 5Y	66.86%
Dividend TTM	-	EV/Sales	10.32	EPS Y/Y TTM	-40.46%	Oper. Margin	17.26%	ATR (14)	8.48	Perf 10Y	1110.27%
Dividend Ex-Date	-	Quick Ratio	1.79	Sales Y/Y TTM	25.99%	Profit Margin	10.01%	RSI (14)	61.23	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.23	EPS Q/Q	-87.70%	SMA20	1.43%	Beta	1.42	Target Price	360.45
Payout	0.00%	Debt/Eq	0.97	Sales Q/Q	32.88%	SMA50	9.96%	Rel Volume	0.71	Prev Close	337.94
Employees	3900	LT Debt/Eq	0.64	Earnings	Aug 07 BMO	SMA200	19.53%	Avg Volume	664.36K	Price	341.78
IPO	May 15, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	27.20% 5.68%	Trades		Volume	472,906	Change	1.14%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-08-25	Resumed	Oppenheimer	Outperform	$365
Jun-16-25	Initiated	Truist	Buy	$365
May-30-25	Initiated	Goldman	Buy	$380
May-13-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$350
Apr-29-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Mar-06-25	Initiated	RBC Capital Mkts	Outperform	$340
Nov-06-24	Initiated	Bernstein	Outperform	$300
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265
Aug-21-23	Downgrade	Robert W. Baird	Outperform → Neutral	$320 → $219
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$343
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$235 → $340
Oct-18-22	Initiated	Barclays	Equal Weight	$238
Oct-12-22	Initiated	Jefferies	Hold	$260
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$310 → $250

Show Previous Ratings

Sep-12-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
12:01AM	3 Reasons Investors Love Insulet (PODD) (StockStory)
Sep-09-25 12:34AM	3 S&P 500 Stocks to Target This Week (StockStory)
Sep-08-25 12:50PM	Oppenheimer sees stronger growth at Boston Scientific (Investing.com)
Aug-29-25 08:00AM	Omnipod Maker Insulet Is In A Buy Zone As Its Market Expands To Millions (Investor's Business Daily)
09:45AM	Loading…
Aug-27-25 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Aug-26-25 11:13AM	Insulet promotes Eric Benjamin to chief operating officer (MedTech Dive)
08:34AM	Insulet Stock: Analyst Estimates & Ratings (Barchart)
Aug-25-25 11:35PM	Patient Monitoring Stocks Q2 Highlights: Insulet (NASDAQ:PODD) (StockStory)
05:00PM	Insulet Elevates Eric Benjamin to Chief Operating Officer (Business Wire)
09:50AM	Why Insulet (PODD) is a Top Momentum Stock for the Long-Term (Zacks)
Aug-22-25 09:55AM	Insulet Gains 77.2% in a Year: What's Driving the Rally? (Zacks)
Aug-21-25 02:03PM	Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating (Investor's Business Daily)
Aug-20-25 01:11PM	Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares. (Investor's Business Daily)
Aug-19-25 04:35PM	Insulet Stock Breaks Out Again As Momentum Continues (Investor's Business Daily)
02:21PM	Loading…
02:21PM	Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV (CNBC TV)
06:00AM	Insulet to Participate in Upcoming Investor Conferences (Business Wire)
Aug-14-25 04:54PM	Stock Market Today: Indexes Mixed; Coherent Hits 3 Sell Signals But New IPO Bullish Jumps 10%; 3 Growth Stocks Set Up Entries (Investor's Business Daily)
03:15PM	Stock Market Today: Dow And Nasdaq Edge Lower As AI Stock Coherent Hits 3 Sell Signals; 3 Growth Stocks Set Up Entries (Live) (Investor's Business Daily)
01:34AM	The Top 5 Analyst Questions From Insulet's Q2 Earnings Call (StockStory)
Aug-12-25 11:40PM	PODD Q2 Deep Dive: Omnipod 5 Adoption and International Expansion Drive Results (StockStory)
08:25AM	Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise (Zacks)
Aug-11-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
Aug-08-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
05:16AM	Tandem, Insulet monitoring CMS payment proposal for diabetes tech (MedTech Dive)
Aug-07-25 05:23PM	S&P 500 Gains and Losses Today: Apple Stock Climbs; Eli Lilly Slumps After Disappointing Trial Results (Investopedia) +9.47%
04:18PM	Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises' (Investor's Business Daily)
02:01PM	Insulet (NASDAQ:PODD) Beats Expectations in Strong Q2, Stock Soars (StockStory)
01:50PM	Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock (Benzinga)
12:06PM	Analyst Report: Insulet Corporation (Morningstar Research)
09:30AM	Loading…
09:30AM	Insulet (PODD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:15AM	Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:13AM	Insulet: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1) (Business Wire)
Aug-05-25 11:07PM	Insulet (PODD) Q2 Earnings: What To Expect (StockStory)
09:15AM	Curious about Insulet (PODD) Q2 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jul-31-25 04:26PM	Analyst Report: DexCom, Inc. (Morningstar Research)
10:00AM	Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-30-25 10:30AM	QualiZeal Welcomes Healthcare Industry Visionary Dr. Aiman Abdel-Malek to Business Advisory Board (Business Wire)
Jul-24-25 08:14AM	What to Expect From Insulet's Q2 2025 Earnings Report (Barchart)
Jul-11-25 08:12PM	Analyst Report: Insulet Corporation (Morningstar Research)
Jul-09-25 02:33PM	Semler Scientific Stock Gets Relative Strength Rating Upgrade (Investor's Business Daily)
12:10PM	Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-08-25 06:00AM	Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire)
Jul-01-25 04:04PM	Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids (Investor's Business Daily)
12:16PM	Apple AI, Wolfspeed bankruptcy, medical device stocks (Yahoo Finance Video)
09:59AM	Medical device maker stocks falls after proposed Medicare payment cuts (Investing.com)
Jun-30-25 06:19AM	5 Insightful Analyst Questions From Insulet's Q1 Earnings Call (StockStory)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-25-25 12:15PM	Diabetes stocks rally after RFK comments on HHS campaign (TipRanks)
Jun-24-25 08:54AM	How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? (Barchart)
Jun-19-25 06:00AM	Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions (Business Wire)
Jun-17-25 09:35AM	Cisco upgraded, CoreWeave downgraded: Wall Streets top analyst calls (TipRanks)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-11-25 09:51AM	Here's Why You Should Retain PODD Stock in Your Portfolio Now (Zacks)
Jun-10-25 08:30AM	Insulets Omnipod 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users (Business Wire)
04:36AM	PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption (StockStory)
Jun-09-25 07:29AM	3 Medical Technology Stocks Outperforming in 2025 (MarketBeat)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
Jun-05-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
12:01AM	3 Reasons Investors Love Insulet (PODD) (StockStory)
Jun-04-25 11:33PM	Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks (StockStory)
09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Jun-03-25 11:30AM	S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF (Zacks)
Jun-02-25 03:18PM	Solventum Stock Earns RS Rating Upgrade (Investor's Business Daily)
May-30-25 10:17AM	Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy (Investing.com)
May-26-25 08:30AM	Insulet Gains 78.5% in a Year: What's Driving the Stock? (Zacks)
May-23-25 06:01AM	Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Business Wire)
May-22-25 09:36AM	Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies (Zacks)
May-21-25 11:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
May-16-25 09:50AM	Here's Why Insulet (PODD) is a Strong Momentum Stock (Zacks)
05:51AM	Dexcom CEO says CGMs fit MAHA agenda very nicely; Tandem preps for new products (MedTech Dive)
May-15-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
May-14-25 12:45PM	Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today (Insider Monkey)
08:45AM	Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer (MarketBeat)
07:20AM	Outlier Money Flows Lift Insulet (FX Empire)
May-13-25 06:00AM	Insulet Announces Publication of 2024 Sustainability Report (Business Wire)
May-12-25 09:10AM	Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised (Zacks)
May-10-25 11:47AM	S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points (Investor's Business Daily)
May-09-25 08:41PM	Analyst Report: Insulet Corporation (Morningstar Research) +20.88%
05:49PM	S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks (Investopedia)
05:49PM	S&P 500 Gains & Losses Today: Index Pulls Back Early Gains Amid Anticipation of Trade Talks (Investopedia)
04:02PM	Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops (Investor's Business Daily)
02:37PM	Insulet Stock Soars to Lead S&P 500 Gainers Friday (Investopedia)
02:16PM	Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops (Yahoo Finance Video)
11:57AM	Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More (Investopedia)
11:29AM	New Insulet CEO Ashley McEvoy sets priorities (MedTech Dive)
10:11AM	Insulet Stock Is the Top S&P 500 Performer Today. Heres Why. (Barrons.com)
08:21AM	Q1 2025 Insulet Corp Earnings Call (Thomson Reuters StreetEvents)
03:39AM	Insulet Corp (PODD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion (GuruFocus.com)
May-08-25 07:01PM	Analyst Report: Insulet Corporation (Morningstar Research)
05:30PM	Insulet (PODD) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates (Zacks)
04:11PM	Insulet Makes A Bullish Post-Earnings Move With A Beat-And-Raise (Investor's Business Daily)
04:11PM	Insulet Jumps After Beating Quarterly Forecasts, Raising 2025 Expectations (Investor's Business Daily)
04:10PM	Insulet: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1) (Business Wire)
May-07-25 05:20PM	Insulet Q1 2025 Earnings Preview (Seeking Alpha)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singh Prem	SVP, Global Operations	Sep 08 '25	Sale	347.49	687	238,726	3,456	Sep 09 04:19 PM
Cousin Laetitia	SVP, Reg, Quality & Compliance	Sep 08 '25	Option Exercise	241.10	797	192,160	4,687	Sep 09 04:16 PM
Cousin Laetitia	SVP, Reg, Quality & Compliance	Sep 08 '25	Sale	348.81	797	278,002	3,890	Sep 09 04:16 PM
Cousin Laetitia	Officer	Sep 08 '25	Proposed Sale	348.81	797	278,000		Sep 08 02:07 PM
Singh Prem	Officer	Sep 08 '25	Proposed Sale	347.48	687	238,718		Sep 08 01:31 PM
Benjamin Eric	EVP, CPXO	Aug 21 '25	Sale	332.23	4,263	1,416,296	16,736	Aug 22 04:16 PM
Benjamin Eric	Officer	Aug 21 '25	Proposed Sale	332.23	4,263	1,416,296		Aug 21 10:21 AM
Singh Prem	SVP, Global Operations	Aug 07 '25	Option Exercise	271.28	1,343	364,325	5,486	Aug 08 04:03 PM
Singh Prem	SVP, Global Operations	Aug 07 '25	Sale	320.00	1,343	429,760	4,143	Aug 08 04:03 PM
Singh Prem	Officer	Aug 07 '25	Proposed Sale	320.00	1,343	429,760		Aug 07 11:35 AM
Singh Prem	SVP, Global Operations	Jun 13 '25	Option Exercise	166.62	1,257	209,441	6,470	Jun 16 04:18 PM
Singh Prem	SVP, Global Operations	Jun 13 '25	Sale	300.05	2,327	698,216	4,143	Jun 16 04:18 PM
Manea Dan	SVP, Chief HR Officer	Jun 13 '25	Sale	300.05	1,300	390,065	9,090	Jun 16 04:16 PM
Singh Prem	Officer	Jun 13 '25	Proposed Sale	300.05	2,327	698,216		Jun 13 10:15 AM
Manea Dan	Officer	Jun 13 '25	Proposed Sale	300.05	1,300	390,065		Jun 13 09:45 AM
BORIO LUCIANA	Director	Jun 09 '25	Sale	305.73	481	147,056	3,087	Jun 10 04:17 PM
BORIO LUCIANA	Director	Jun 09 '25	Proposed Sale	305.72	481	147,054		Jun 09 01:08 PM
Hollingshead James	Former Officer	May 16 '25	Proposed Sale	323.10	15,605	5,041,964		May 16 04:40 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Option Exercise	95.43	5,278	503,680	28,458	May 15 04:25 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Sale	318.47	5,278	1,680,885	23,180	May 15 04:25 PM
Hopfield Jessica	Director	May 13 '25	Option Exercise	28.87	5,235	151,134	32,152	May 14 04:15 PM
Hopfield Jessica	Director	May 13 '25	Sale	317.54	5,235	1,662,322	26,917	May 14 04:15 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Option Exercise	92.11	3,001	276,422	23,907	May 14 04:08 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Sale	320.00	3,001	960,320	20,906	May 14 04:08 PM
Kapples John W.	Officer	May 14 '25	Proposed Sale	318.47	5,278	1,680,901		May 14 12:32 PM
Field Mark N	Former Officer	May 13 '25	Proposed Sale	321.31	2,457	789,459		May 13 01:44 PM
Benjamin Eric	Officer	May 13 '25	Proposed Sale	320.00	3,001	960,320		May 13 12:51 PM
Hopfield Jessica	Director	May 13 '25	Proposed Sale	317.54	5,235	1,662,322		May 13 10:19 AM
Frederick Wayne A.I.	Director	Mar 25 '25	Sale	275.00	1,825	501,875	3,231	Mar 26 04:22 PM
Frederick Wayne A.I.	Director	Mar 25 '25	Proposed Sale	275.00	1,825	501,875		Mar 25 10:30 AM
Benjamin Eric	EVP, CPXO	Mar 03 '25	Option Exercise	56.52	5,146	290,873	20,906	Mar 04 04:09 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Option Exercise	65.00	5,075	329,898	23,777	Jan 22 04:10 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Sale	280.00	12,394	3,470,320	11,383	Jan 22 04:10 PM
Benjamin Eric	Officer	Jan 21 '25	Proposed Sale	280.00	12,394	3,470,320		Jan 21 10:56 AM
Benjamin Eric	EVP, CPXPO	Dec 16 '24	Sale	267.60	4,362	1,167,271	18,702	Dec 17 04:14 PM
Benjamin Eric	Officer	Dec 16 '24	Proposed Sale	267.60	4,362	1,167,271		Dec 16 10:38 AM
Budden Lauren	Group VP, CAO and Controller	Dec 10 '24	Sale	275.62	915	252,192	5,733	Dec 11 04:00 PM
Budden Lauren	Officer	Dec 10 '24	Proposed Sale	275.62	915	252,194		Dec 10 05:18 PM
BORIO LUCIANA	Director	Nov 12 '24	Sale	274.80	508	139,598	2,790	Nov 13 04:01 PM
BORIO LUCIANA	Director	Nov 12 '24	Proposed Sale	274.81	508	139,602		Nov 12 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PODD

Insulet Corporation

Upgrade your FINVIZ experience